Understanding how ribosomes regulate gene expression in cells
Mechanism for post-transcriptional gene regulation by Ribothrypsis
This study is exploring a new way that our cells break down messenger RNA, which is important for making proteins, to help us understand how this process works and why it matters for keeping our cells healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11053546 on NIH RePORTER |
What this research studies
This research investigates a newly discovered mechanism called ribothrypsis, which plays a crucial role in the decay of messenger RNA (mRNA) during protein synthesis. By using advanced sequencing methods, the researchers aim to uncover how ribosomes can influence the stability and degradation of mRNA, challenging the traditional understanding of gene regulation. The study focuses on both ends of mRNA molecules to gain insights into this process, which is essential for maintaining normal cellular function. The findings could provide new perspectives on gene expression regulation in various organisms, including humans.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to gene expression dysregulation, such as certain genetic disorders or cancers.
Not a fit: Patients with conditions unrelated to gene expression or those who do not have a genetic component to their illness may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for manipulating gene expression, which may have implications for treating various diseases.
How similar studies have performed: This research builds on existing knowledge of mRNA decay mechanisms, but the specific approach of studying ribothrypsis is novel and has not been extensively tested in prior studies.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Ibrahim, Fadia Fayez — Thomas Jefferson University
- Study coordinator: Ibrahim, Fadia Fayez
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.